Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review

MLA

Mengyuan Liu, et al. “Insights into Uveitis from Brentuximab Vedotin in Refractory Hodgkin’s Lymphoma: A Case Report and Brief Review.” Frontiers in Oncology, vol. 14, Aug. 2024. EBSCOhost, https://doi.org/10.3389/fonc.2024.1419145.

APA

Mengyuan Liu, Kexing Ren, Ping Ai, & Liqun Zou. (2024). Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1419145

Chicago

Mengyuan Liu, Kexing Ren, Ping Ai, and Liqun Zou. 2024. “Insights into Uveitis from Brentuximab Vedotin in Refractory Hodgkin’s Lymphoma: A Case Report and Brief Review.” Frontiers in Oncology 14 (August). doi:10.3389/fonc.2024.1419145.